You limited your search to:

 Collection: Congressional Research Service Reports
Fair Credit Reporting Act: Frequently Asked Questions
As financial privacy issues are debated in Congress, numerous questions about the Fair Credit Reporting Act (FCRA) have emerged. Enacted in 1970, the Fair Credit Reporting Act is the federal statute that establishes a regulatory framework for credit reporting in the United States and establishes a consumer’s rights with respect to his or her credit report. This report attempts to answer frequently asked questions about the Fair Credit Reporting Act. digital.library.unt.edu/ark:/67531/metacrs4075/
Fair Credit Reporting Act: Preemption of State Law
As financial privacy issues are debated in Congress, numerous questions about the Fair Credit Reporting Act (FCRA) have emerged. Enacted in 1970, the Fair Credit Reporting Act is the federal statute that establishes a regulatory framework for credit reporting in the United States and establishes a consumer’s rights with respect to his or her credit report. This report attempts to answer frequently asked questions about the Fair Credit Reporting Act. digital.library.unt.edu/ark:/67531/metacrs4074/
Ecstasy: Legislative Proposals in the 107th Congress to Control MDMA
Legislation has been proposed in the 107th Congress to combat the use and abuse of Ecstasy (MDMA) and other “club drugs.” In a 2001 survey, 12% of 12th graders reported ever having taken the drug. The Ecstasy Anti-Proliferation Act of 2000, enacted by the 106th Congress, directed the U.S. Sentencing Commission to increase penalties for Ecstasy offenses. As of March 2001, MDMA penalties became more severe than for powder cocaine but less severe than for heroin. digital.library.unt.edu/ark:/67531/metacrs4073/
Ecstasy: Actions of the 107th Congress to Control MDMA
Legislation has been proposed in the 107th Congress to combat the use and abuse of Ecstasy (MDMA) and other “club drugs.” In a 2001 survey, 12% of 12th graders reported ever having taken the drug. The Ecstasy Anti-Proliferation Act of 2000, enacted by the 106th Congress, directed the U.S. Sentencing Commission to increase penalties for Ecstasy offenses. As of March 2001, MDMA penalties became more severe than for powder cocaine but less severe than for heroin. digital.library.unt.edu/ark:/67531/metacrs2339/
Ecstasy: Actions of the 107th Congress to Control MDMA
Legislation has been proposed in the 107th Congress to combat the use and abuse of Ecstasy (MDMA) and other “club drugs.” In a 2001 survey, 12% of 12th graders reported ever having taken the drug. The Ecstasy Anti-Proliferation Act of 2000, enacted by the 106th Congress, directed the U.S. Sentencing Commission to increase penalties for Ecstasy offenses. As of March 2001, MDMA penalties became more severe than for powder cocaine but less severe than for heroin. digital.library.unt.edu/ark:/67531/metacrs2338/
Ecstasy: Actions of the 107th Congress to Control MDMA
Legislation has been proposed in the 107th Congress to combat the use and abuse of Ecstasy (MDMA) and other “club drugs.” In a 2001 survey, 12% of 12th graders reported ever having taken the drug. The Ecstasy Anti-Proliferation Act of 2000, enacted by the 106th Congress, directed the U.S. Sentencing Commission to increase penalties for Ecstasy offenses. As of March 2001, MDMA penalties became more severe than for powder cocaine but less severe than for heroin. digital.library.unt.edu/ark:/67531/metacrs2337/
Identity Theft and the Fair Credit Reporting Act: An Analysis of
No Description digital.library.unt.edu/ark:/67531/metacrs4072/
Identity Theft and the Fair Credit Reporting Act: An Analysis of
No Description digital.library.unt.edu/ark:/67531/metacrs4071/
Identity Theft and the Fair Credit Reporting Act: An Analysis of
No Description digital.library.unt.edu/ark:/67531/metacrs4070/
Prescription Drugs: Importation for Personal Use
No Description digital.library.unt.edu/ark:/67531/metacrs1522/
Asbestos Compensation Act of 2000
This report summarizes H.R. 1283, 106th Congress, the Asbestos Compensation Act of 2000, as ordered to be reported with amendments by the House Committee on the Judiciary on March 16, 2000. The bill would create an administrative procedure for asbestos liability claims. digital.library.unt.edu/ark:/67531/metacrs1122/
Importing Prescription Drugs: Objectives, Options, and Outlook
No Description digital.library.unt.edu/ark:/67531/metacrs5777/
Prescription Drug Importation and Internet Sales: A Legal Overview
No Description digital.library.unt.edu/ark:/67531/metacrs5775/
Importing Prescription Drugs
No Description digital.library.unt.edu/ark:/67531/metacrs2336/
Importing Prescription Drugs
No Description digital.library.unt.edu/ark:/67531/metacrs2335/
Medicare: Major Prescription Drug Provisions of Selected Bills
No Description digital.library.unt.edu/ark:/67531/metacrs2334/
Medicare: Major Prescription Drug Provisions of Selected Bills
No Description digital.library.unt.edu/ark:/67531/metacrs2333/
Medicare: Major Prescription Drug Provisions of Selected Bills
No Description digital.library.unt.edu/ark:/67531/metacrs2332/
President Bush's Proposed Medicare-Endorsed Drug Discount Card Initiative: Status and Issues
No Description digital.library.unt.edu/ark:/67531/metacrs4069/
President Bush's Proposed Medicare-Endorsed Drug Discount Card Initiative: Status and Issues
No Description digital.library.unt.edu/ark:/67531/metacrs2331/
President Bush's Proposed Medicare-Endorsed Drug Discount Card Initiative: Status and Issues
No Description digital.library.unt.edu/ark:/67531/metacrs2330/
Firestone Tire Recall: NHTSA, Industry, and Congressional Responses
No Description digital.library.unt.edu/ark:/67531/metacrs1521/
The Cost of Prescription Drugs for the Uninsured Elderly and Legislative Approaches
The purpose of this report is to explain why many of those who are least able to afford high drug costs are those who are most frequently charged the most. This report describes the basic economic theory underlying price differentiation and, in the context of the pharmaceutical market, analyzes the role and behavior of pharmacy benefit managers (PBMs), pharmaceutical manufacturers, and retail pharmacies, respectively. It also looks at a number of the criticisms that have been made of the practice of differential pricing. Finally, this report discusses various policy approaches aimed at assisting the elderly to purchase prescription drugs. digital.library.unt.edu/ark:/67531/metacrs1520/
Products Liability: A Legal Overview
No Description digital.library.unt.edu/ark:/67531/metacrs4068/
Products Liability: A Legal Overview
No Description digital.library.unt.edu/ark:/67531/metacrs4067/
Products Liability: A Legal Overview
No Description digital.library.unt.edu/ark:/67531/metacrs4066/
Products Liability: A Legal Overview
No Description digital.library.unt.edu/ark:/67531/metacrs4065/
Products Liability: A Legal Overview
No Description digital.library.unt.edu/ark:/67531/metacrs4064/
Products Liability: A Legal Overview
No Description digital.library.unt.edu/ark:/67531/metacrs4063/
Products Liability: A Legal Overview
No Description digital.library.unt.edu/ark:/67531/metacrs4062/
Products Liability: A Legal Overview
No Description digital.library.unt.edu/ark:/67531/metacrs4061/
Products Liability: A Legal Overview
No Description digital.library.unt.edu/ark:/67531/metacrs4060/
Products Liability: A Legal Overview
No Description digital.library.unt.edu/ark:/67531/metacrs4059/
Products Liability: A Legal Overview
No Description digital.library.unt.edu/ark:/67531/metacrs2329/
Products Liability: A Legal Overview
No Description digital.library.unt.edu/ark:/67531/metacrs2328/
Products Liability: A Legal Overview
No Description digital.library.unt.edu/ark:/67531/metacrs2327/
Products Liability: A Legal Overview
No Description digital.library.unt.edu/ark:/67531/metacrs2326/
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
No Description digital.library.unt.edu/ark:/67531/metacrs5774/
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
No Description digital.library.unt.edu/ark:/67531/metacrs4058/
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
No Description digital.library.unt.edu/ark:/67531/metacrs4057/
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
No Description digital.library.unt.edu/ark:/67531/metacrs4056/
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
No Description digital.library.unt.edu/ark:/67531/metacrs4055/
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
No Description digital.library.unt.edu/ark:/67531/metacrs4054/
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
No Description digital.library.unt.edu/ark:/67531/metacrs4053/
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
No Description digital.library.unt.edu/ark:/67531/metacrs4052/
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
No Description digital.library.unt.edu/ark:/67531/metacrs4051/
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
No Description digital.library.unt.edu/ark:/67531/metacrs2325/
The Hatch-Waxman Act: Proposed Legislative Changes
No Description digital.library.unt.edu/ark:/67531/metacrs2324/
Consumer Bankruptcy Reform: Proposals Before the 105th Congress
This report examines current consumer bankruptcy practice and the proposals set forth in the reform bills. Also considered are the legislative history of the current consumer bankruptcy scheme, and topics likely to be debated as Congress proceeds to consider consumer bankruptcy reform. digital.library.unt.edu/ark:/67531/metacrs599/
Prescription Drug User Fee Act of 1992: Effects on Bringing New Drugs to Market
No Description digital.library.unt.edu/ark:/67531/metacrs416/